Management of warfarin-related intracerebral hemorrhage

References

• Gage BF, Milligan PE. Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements. Thromb. Res.117(1–2), 55–59; discussion 65–67 (2005).
   PubMed Web of Science ®Google Scholar
• Kresge N, Simoni RD, Hill RL. Hemorrhagic sweet clover disease, dicumarol and warfarin: the work of Karl Paul Link. J. Biol. Chem.280(8), 5 (2005).
   PubMed Web of Science ®Google Scholar
• Stahmann MA, Huebner CF, Link KP. Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent. J. Biol. Chem.138, 513–527 (1941).
   Google Scholar
• Go AS, Hylek EM, Chang Y et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?JAMA290(20), 2685–2692 (2003).
   PubMed Web of Science ®Google Scholar
• Hart RG. Atrial fibrillation and stroke prevention. N. Engl. J. Med.349(11), 1015–1016 (2003).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Fuster V, Ansell J, Halperin JL; American Heart Association/American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J. Am. Coll. Cardiol.41(9), 1633–1652 (2003).
   PubMed Web of Science ®Google Scholar
• Wadelius M, Chen LY, Downes K et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J.5(4), 262–270 (2005).
   PubMed Web of Science ®Google Scholar
• Gage BF. Pharmacogenetics-based coumarin therapy. Hematology467–473 (2006).
   Google Scholar
• Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Thromb. Haemost.91(1), 87–94 (2004).
   PubMed Web of Science ®Google Scholar
• Hart RG. What causes intracerebral hemorrhage during warfarin therapy?Neurology55(7), 907–908 (2000).
   PubMed Web of Science ®Google Scholar
• Flaherty ML, Kissela B, Woo D et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology68(2), 116–121 (2007).
   PubMed Web of Science ®Google Scholar
• Flaherty ML, Kissela B, Woo D et al. Atrial fibrillation. [Erratum appears in N. Engl. J. Med.344(24), 1876 (2001)]. N. Engl. J. Med.344(14), 1067–1078 (2001).
   PubMed Web of Science ®Google Scholar
• Aguilar MI, Hart RG, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst. Rev.3, CD006186 (2007).
   PubMed Web of Science ®Google Scholar
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.N. Engl. J. Med.323(22), 1505–1511 (1990).
   Google Scholar
• EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet342(8882), 1255–1262 (1993).
   PubMed Web of Science ®Google Scholar
• Fang MC, Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch. Intern. Med.164(1), 55–60 (2004).
   PubMed Web of Science ®Google Scholar
• Hart RG, Halperin JL, Pearce LA et al.; stroke Prevention in Atrial Fibrillation Investigators. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med.138(10), 831–838 (2003).
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann. Intern. Med.146(12), 857–867 (2007).
   PubMed Web of Science ®Google Scholar
• Smith NL, Psaty BM, Furberg CD et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch. Intern. Med.159(14), 1574–1578 (1999).
   PubMedGoogle Scholar
• Mohr J, Thompson JLP, Lazar RM et al.; for the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med.345, 1444–1451 (2001).
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann. Neurol.42(6), 857–865 (1997).
   PubMed Web of Science ®Google Scholar
• Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke36(7), 1588–1593 (2005).
   PubMed Web of Science ®Google Scholar
• Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation115(21), 2689–2696 (2007).
   PubMed Web of Science ®Google Scholar
• Kissela B, Schneider A, Kleindorfer D et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke35(2), 426–431 (2004).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N. Engl. J. Med.344(19), 1450–1460 (2001).
   PubMed Web of Science ®Google Scholar
• Aguilar MI, Hart RG, Kase CS et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin. Proc.82(1), 82–92 (2007).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Giles WH, Croft JB. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology52(8), 1617–1621 (1999).
   PubMed Web of Science ®Google Scholar
• Berwaerts J, Robb OJ, Jeffers TA, Webster J. Intracerebral haemorrhages and oral anticoagulation in the north of Scotland. Scott. Med. J.45(4), 101–104 (2000).
   PubMed Web of Science ®Google Scholar
• Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology63(6), 1059–1064 (2004).
   PubMed Web of Science ®Google Scholar
• Sjöblom L, Hårdemark HG, Lindgren A et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke32(11), 2567–2574 (2001).
   PubMed Web of Science ®Google Scholar
• Yasaka M, Minematsu K, Naritomi H, Sakata T, Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb. Haemost.89(2), 278–283 (2003).
   PubMed Web of Science ®Google Scholar
• Yasaka M, Oomura M, Ikeno K, Naritomi H, Minematsu K. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Ann. Hematol.82(2), 121–123 (2003).
   PubMed Web of Science ®Google Scholar
• Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J. Neurol. Sci. (261), 74–79 (2007).
   PubMedGoogle Scholar
• Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke26(8), 1471–1477 (1995).
   PubMed Web of Science ®Google Scholar
• Ichikawa K, Yanagihara C. Sedimentation level in acute intracerebral hematoma in a patient receiving anticoagulation therapy: an autopsy study. Neuroradiology40(6), 380–382 (1998).
   PubMed Web of Science ®Google Scholar
• Kase CS, Robinson RK, Stein RW et al. Anticoagulant-related intracerebral hemorrhage. Neurology35(7), 943–948 (1985).
   PubMed Web of Science ®Google Scholar
• Neau JP, Couderq C, Ingrand P, Blanchon P, Gil R; VGP Study Group. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc. Dis.11(3), 195–200 (2001).
   PubMed Web of Science ®Google Scholar
• Laissy JP, Normand G, Monroc M, Duchateau C, Alibert F, Thiebot J. Spontaneous intracerebral hematomas from vascular causes. Predictive value of CT compared with angiography. Neuroradiology33(4), 291–295 (1991)
   PubMed Web of Science ®Google Scholar
• Woo D, Sauerbeck LR, Kissela BM et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke33(5), 1190–1195 (2002).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Fiebach JB. Intracranial hemorrhage: the role of magnetic resonance imaging. Neurocrit. Care1(1), 31–45 (2004).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Chalela JA, Saver JL et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA292(15), 1823–1830 (2004).
   PubMed Web of Science ®Google Scholar
• Kothari RU, Brott T, Broderick JP et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke27(8), 1304–1305 (1996).
   PubMed Web of Science ®Google Scholar
• Broderick JP, Adams HP Jr, Barsan W et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke30(4), 905–915 (1999).
   PubMed Web of Science ®Google Scholar
• Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke24(7), 987–993 (1993).
   PubMed Web of Science ®Google Scholar
• Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke28(1), 1–5 (1997).
   PubMed Web of Science ®Google Scholar
• Toyoda K, Okada Y, Minematsu K et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology65(7), 1000–1004 (2005).
   PubMed Web of Science ®Google Scholar
• Goldstein JN, Fazen LE, Snider R et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology68(12), 889–894 (2007).
   PubMed Web of Science ®Google Scholar
• Mayer SA, Brun NC, Begtrup K et al.; Recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med.352(8), 777–785 (2005).
   Google Scholar
• Mayer SA; FTS Committee. Complications in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology69(3), 319–320 (2007).
   PubMed Web of Science ®Google Scholar
• Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch. Intern. Med.164(8), 880–884 (2004).
   PubMed Web of Science ®Google Scholar
• Själander A, Engström G, Berntorp E, Svensson P. Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population. J. Intern. Med.254(5), 434–438 (2003).
   PubMed Web of Science ®Google Scholar
• Freeman WD, Brott TG, Barrett KM et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin. Proc.79(12), 1495–1500 (2004).
   PubMed Web of Science ®Google Scholar
• Fang MC, Chang Y, Hylek EM et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann. Intern. Med.141(10), 745–752 (2004).
   PubMed Web of Science ®Google Scholar
• Hemphill JC III, Bonovich DC, Besmertis L et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke32(4), 891–897 (2001).
   PubMed Web of Science ®Google Scholar
• Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit. Care Med.27(3), 617–621 (1999).
   PubMed Web of Science ®Google Scholar
• Vemmos KN, Tsivgoulis G, Spengos K et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J. Intern. Med.255(2), 257–265 (2004).
   PubMed Web of Science ®Google Scholar
• Huang CH, Chen WJ, Chang WT, Yip PK, Lee YT. QTc dispersion as a prognostic factor in intracerebral hemorrhage. Am. J. Emerg. Med.22(3), 141–144 (2004).
   PubMed Web of Science ®Google Scholar
• Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J. Neurol. Neurosurg. Psychiatr.76(3), 349–353 (2005).
   PubMed Web of Science ®Google Scholar
• Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit. Care Med.29(3), 635–640 (2001).
   PubMed Web of Science ®Google Scholar
• Hemphill JC III, Bleck T, Carhuapoma JR et al. Neurocritical Care Society. Is neurointensive care really optional for comprehensive stroke care? Stroke36(11), 2344–2345 (2005).
   PubMedGoogle Scholar
• Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J. Neurosurg. Anesthesiol.13(2), 83–92 (2001).
   PubMed Web of Science ®Google Scholar
• Suarez JI, Zaidat OO, Suri MF et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit. Care Med.32(11), 2311–2317 (2004).
   PubMed Web of Science ®Google Scholar
• Sung GY. Outcomes of neurocritical care. Curr. Neurol. Neurosci. Rep.1(6), 593–598 (2001).
   PubMedGoogle Scholar
• Varelas PN, Spanaki MV, Hacein-Bey L. Documentation in medical records improves after a neurointensivist’s appointment. Neurocrit. Care3(3), 234–236 (2005).
   PubMed Web of Science ®Google Scholar
• Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin. Proc.80(3), 420–433 (2005).
   PubMed Web of Science ®Google Scholar
• Broderick J, Connolly S, Feldmann E et al.; American Stroke Association Stroke Council; High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke38(6), 2001–2023 (2007).
   PubMed Web of Science ®Google Scholar
• Micromedex. Physician’s Desk Reference (2001).
   Google Scholar
• Ardelt AA, Arenberg S, Kulesza P, Streiff MB. Anticoagulation reversal in patients with intracerebral hemorrhage: a survey of neurocritical care society members. Neurocrit. Care6, 240 (2007) (Abstract 053).
   Google Scholar
• Goldstein JN, Thomas SH, Frontiero V et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke37(1), 151–155 (2006).
   PubMed Web of Science ®Google Scholar
• Lee SB, Manno EM, Layton KF, Wijdicks EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology67(7), 1272–1274 (2006).
   PubMed Web of Science ®Google Scholar
• Olson JD. Mechanisms of hemostasis. Effect on intracerebral hemorrhage. Stroke24(12 Suppl.), I109–I114 (1993).
   Web of Science ®Google Scholar
• Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N. Engl. J. Med.349(7), 675–683 (2003).
   PubMed Web of Science ®Google Scholar
• Bertram M, Bonsanto M, Hacke W, Schwab S. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J. Neurol.247(3), 209–214 (2000).
   PubMed Web of Science ®Google Scholar
• Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery45(5), 1113–1118; discussion 1118–1119 (1999).
   PubMed Web of Science ®Google Scholar
• Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br. J. Neurosurg,14(5), 458–461 (2000).
   PubMed Web of Science ®Google Scholar
• Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke23(7), 972–977 (1992).
   PubMed Web of Science ®Google Scholar
• Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb. Haemost.77(3), 477–480 (1997).
   PubMed Web of Science ®Google Scholar
• Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb. Res.115(6), 455–459 (2005).
   PubMed Web of Science ®Google Scholar
• Brody DL, Aiyagari V, Shackleford AM, Diringer MN. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit. Care2(3), 263–267 (2005).
   PubMed Web of Science ®Google Scholar
• Freeman WD. Recombinant factor VIIa for rapid warfarin anticoagulation reversal in acute intracranial hemorrhage in 50 patients. Presented at: The Neurocritical Care Society 5 November, 2006.
   Google Scholar
• O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA295(3), 293–298 (2006).
   PubMed Web of Science ®Google Scholar
• Steiner T, Diringer MN, Schneider D et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery59(4), 767–773; discussion 773–774 (2006).
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Demchuk AM, Watson T, Barber PA, Hill MD. Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa. Neurology67(6), 1096 (2006).
   PubMedGoogle Scholar
• Sugg RM, Gonzales NR, Matherne DE et al. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology67(6), 1053–1055 (2006).
   PubMed Web of Science ®Google Scholar
• Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann. Intern. Med.137(11), 884–888 (2002).
   PubMed Web of Science ®Google Scholar
• Fewel ME, Park P. The emerging role of recombinant-activated factor VII in neurocritical care. Neurocrit. Care1(1), 19–29 (2004).
   PubMed Web of Science ®Google Scholar
• Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J. Neurosurg.98(4), 737–740 (2003).
   PubMed Web of Science ®Google Scholar
• Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost–effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke37(11), 2751–2758 (2006).
   PubMed Web of Science ®Google Scholar
• Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke28(12), 2370–2375 (1997).
   PubMed Web of Science ®Google Scholar
• Hughes M, Lip GY. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM10, 599–607 (2007).
   Google Scholar
• Rosand J, Hylek EM, O’Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology55(7), 947–951 (2000).
   PubMed Web of Science ®Google Scholar
• Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology57(1), 18–24 (2001).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Mohammad YM, Yahia AM et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J. Intensive Care Med.20(1), 34–42 (2005).
   PubMedGoogle Scholar
• Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke35(6), 1364–1367 (2004).
   PubMed Web of Science ®Google Scholar
• Zazulia AR, Diringer MN, Videen TO et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J. Cereb. Blood Flow Metab.21(7), 804–810 (2001).
   PubMed Web of Science ®Google Scholar
• Xi G, Keep RF, Hoff JT. Pathophysiology of brain edema formation. Neurosurg. Clin. N. Am.13(3), 371–383 (2002).
   PubMed Web of Science ®Google Scholar
• Gebel JM Jr, Jauch EC, Brott TG et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke33(11), 2636–2641 (2002).
   PubMed Web of Science ®Google Scholar
• Gebel JM Jr, Jauch EC, Brott TG et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke33(11), 2631–2635 (2002).
   PubMed Web of Science ®Google Scholar
• Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Curr. Opin. Crit. Care10(2), 94–100 (2004).
   PubMedGoogle Scholar
• Levine JM, Snider R, Finkelstein D et al. Early edema in warfarin-related intracerebral hemorrhage. Neurocrit. Care7, 58–63 (2007).
   PubMed Web of Science ®Google Scholar
• Farooq MU, Naravetla B, Majid A, Gupta R, Pysh JJ, Kassab MY. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit. Care (7), 36–39 (2007).
   PubMed Web of Science ®Google Scholar
• Naval NS, Abdelhak TA, Urrunaga N, Zeballos P, Mirski MA, Carhuapoma JR. An association of prior statin use with decreased perihematomal edema.Neurocrit. Care8(1), 13–18 (2008).
   PubMed Web of Science ®Google Scholar
• Akdemir H, Selcuklu A, Pasaoglu A et al. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg. Rev.18, 95–100 (1995).
   PubMed Web of Science ®Google Scholar
• Coplin WM, Vinas FC, Agris JM et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke29, 1573–1579 (1998).
   PubMed Web of Science ®Google Scholar
• Naff NJ, Carhuapoma JR, Williams MA et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke31, 841–847 (2000).
   PubMed Web of Science ®Google Scholar
• Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br. J. Neurosurg.12, 234–239 (1998).
   PubMed Web of Science ®Google Scholar
• Naff NJ, Hanley DF, Keyl PM et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized double-blind, controlled trial. Neurosurgery54, 577–583 (2004).
   PubMed Web of Science ®Google Scholar
• Engelhard HH, Andrews CO, Slavin KV, Charbel FT. Current management of intraventricular hemorrhage. Surg. Neurol.60, 15–22 (2003).
   PubMedGoogle Scholar
• Hanley DF, Hacke W. Critical care and emergency medicine neurology in stroke. Stroke36, 205–207 (2005).
   PubMed Web of Science ®Google Scholar
• Ionita CC, Ferrara J, McDonagh DL, Grossi P, Graffagnino C. Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage. Neurocrit. Care3(3), 246–248 (2005).
   PubMed Web of Science ®Google Scholar
• Cruz J, Minoja G, Okuchi K. Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery51, 628–637 (2002).
   PubMed Web of Science ®Google Scholar
• Larive LL, Rhoney DH, Parker D Jr et al. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit. Care1, 435–440 (2004).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery44, 1055–1063 (1999).
   PubMed Web of Science ®Google Scholar
• Ogden AT, Mayer SA, Connolly ES Jr. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery57, 207–215 (2005).
   PubMedGoogle Scholar
• Qureshi AI, Suarez JI, Bhardwaj A et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit. Care Med.26, 440–446 (1998).
   PubMed Web of Science ®Google Scholar
• Suarez JI, Qureshi AI, Bhardwaj A et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit. Care Med.26, 1118–1122 (1998).
   PubMed Web of Science ®Google Scholar
• Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke31(10), 2511–2516 (2000).
   PubMed Web of Science ®Google Scholar
• Mendelow AD, Gregson BA, Fernandes HM et al.; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet365(9457), 387–397 (2005).
   PubMed Web of Science ®Google Scholar
• Nishihara T, Nagata K, Tanaka S et al. Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit. Care2(1), 67–74 (2005).
   PubMed Web of Science ®Google Scholar
• Vespa P, McArthur D, Miller C et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit. Care2(3), 274–281 (2005).
   PubMed Web of Science ®Google Scholar
• Murthy JM, Chowdary GV, Murthy TV, Bhasha PS, Naryanan TJ. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocrit. Care2(3), 258–262 (2005).
   PubMed Web of Science ®Google Scholar
• Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann. Intern. Med.124(11), 970–979 (1996).
   PubMed Web of Science ®Google Scholar
• Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann. Intern. Med.120(11), 897–902 (1994).
   PubMed Web of Science ®Google Scholar
• van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch. Intern. Med.153(13), 1557–1562 (1993).
   PubMed Web of Science ®Google Scholar
• Lackie CL, Garbarino KA, Pruetz JA. Warfarin therapy for atrial fibrillation in the elderly. Ann. Pharmacother.36(2), 200–204 (2002).
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-presure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet358, 1033–1041 (2001).
   Google Scholar
• Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N. Engl. J. Med.335(8), 540–546 (1996).
   PubMed Web of Science ®Google Scholar
• Diener HC, Bogousslavsky J, Brass LM et al.; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet364(9431), 331–337 (2004).
   PubMed Web of Science ®Google Scholar
• Fazekas F, Kleinert R, Roob G et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol.20(4), 637–642 (1999).
   PubMed Web of Science ®Google Scholar
• Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke31(11), 2665–2669 (2000).
   PubMed Web of Science ®Google Scholar
• Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology52(5), 991–994 (1999).
   PubMed Web of Science ®Google Scholar
• Osborn AG. Diagnostic Neuroradiology (1st Edition). Mosby, MO, USA936 (1994).
   Google Scholar
• Fan YH, Mok VC, Lam WW, Hui AC, Wong S. Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts. J. Neurol.251(5), 537–541 (2004).
   PubMed Web of Science ®Google Scholar
• Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke35(6), 1415–1420 (2004).
   PubMed Web of Science ®Google Scholar
• Naka H, Nomura E, Wakabayashi S, Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. AJNR Am. J. Neuroradiol.25(5), 714–719 (2004).
   PubMed Web of Science ®Google Scholar
• Derex L, Hermier M, Adeleine P et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J. Neurol. Neurosurg. Psychiatr.76(1), 70–75 (2005).
   PubMed Web of Science ®Google Scholar
• Derex L, Nighoghossian N, Hermier M et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc. Dis.17(2–3), 238–241 (2004).
   PubMed Web of Science ®Google Scholar
• Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology53(6), 1319–1327 (1999).
   PubMed Web of Science ®Google Scholar
• Ferro JM. Update on intracerebral haemorrhage. J. Neurol.253(8), 985–999 (2006).
   PubMed Web of Science ®Google Scholar
• Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am. J. Med.105(2), 91–99 (1998).
   PubMed Web of Science ®Google Scholar
• Kuijer PM, Hutten BA, Prins MH, Büller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch. Intern. Med.159(5), 457–460 (1999).
   PubMed Web of Science ®Google Scholar
• Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest130(5), 1390–1396 (2006).
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA285(22), 2864–2870 (2001).
   PubMed Web of Science ®Google Scholar
• Gage BF, Yan Y, Milligan PE et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am. Heart J.151(3), 713–719 (2006).
   PubMed Web of Science ®Google Scholar
• Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br. J. Haematol.116(3), 619–624 (2002).
   PubMed Web of Science ®Google Scholar
• Nitu IC, Perry DJ, Lee CA. Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal. Clin. Lab. Haematol.20(6), 363–367 (1998).
   PubMedGoogle Scholar
• Sørensen B, Johansen P, Nielsen GL, Sørensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul. Fibrinolysis14(5), 469–477 (2003).
   PubMed Web of Science ®Google Scholar
• Riegert-Johnson DL, Volcheck GW. The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. Ann. Allergy Asthma Immunol.89(4), 400–406 (2002).
   PubMed Web of Science ®Google Scholar
• Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med.28(Suppl. 2), S248–S255 (2002).
   Web of Science ®Google Scholar
• NovoSeven Package Insert.
   Google Scholar
• Jauch EC, Lindsell CJ, Adeoye O et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke37(8), 2061–2065 (2006).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit. Care Med.27(5), 965–971 (1999).
   PubMed Web of Science ®Google Scholar
• Aguilar MI, Benavente OR. Anticoagulation therapy for secondary stroke prevention. Curr. Med. Lit. Stroke Rev.9(3), 189–195 (2005).
   Google Scholar
• Qureshi AI, Bliwise DL, Bliwise NG et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit. Care Med.27, 480–485 (1999).
   PubMed Web of Science ®Google Scholar